Skip to main content
. 2021 Apr 28;11:9164. doi: 10.1038/s41598-021-88676-9

Figure 9.

Figure 9

Prognostic value of LCP2 in melanoma patients receiving immune checkpoint blockade. Kaplan–Meier curves of OS (A) and PFS (B) for patients with low and high expression of LCP2 in the Gide2019_PD1 cohort who received anti-PD-1 immunotherapy. OS overall survival, PFS progression-free survival.